{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:53:44Z","timestamp":1790704424173,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/cmr.0b013e32835e7734","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T09:42:17Z","timestamp":1360748537000},"page":"96-101","source":"Crossref","is-referenced-by-count":16,"title":["Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma"],"prefix":"10.1097","volume":"23","author":[{"given":"Alessandro M.","family":"Minisini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Pascoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Intersimone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Poletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Driol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Spizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpiero","family":"Fasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Di Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Supp 5","key":"R1-2-20210129","first-page":"v197","article-title":"Melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"21","author":"Dummer","year":"2010","journal-title":"Ann Oncol"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1470-2045(05)01766-3","article-title":"Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment.","volume":"6","author":"Toi","year":"2005","journal-title":"Lancet Oncol"},{"key":"R3-2-20210129","first-page":"709","article-title":"Clinicopathologic and prognostic significance of an human angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma.","volume":"19","author":"Takebayashi","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1131::AID-CNCR25>3.0.CO;2-P","article-title":"Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.","volume":"88","author":"Arima","year":"2000","journal-title":"Cancer"},{"key":"R5-2-20210129","first-page":"709","article-title":"Expression of thymidine phosphorylase in human cervical cancer.","volume":"19","author":"Hata","year":"1999","journal-title":"Anticancer Res"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1349-7006.1996.tb00219.x","article-title":"Expression of thymidine phosphorylase in human gastric carcinoma.","volume":"87","author":"Takebayashi","year":"1996","journal-title":"Jpn J Cancer Res"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"key":"R8-2-20210129","first-page":"987","article-title":"Cyclooxygenase-2 expression is upregulated in human pancreatic cancer.","volume":"59","author":"Tucker","year":"1999","journal-title":"Cancer Res"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/hep.510290355","article-title":"Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor differentiation.","volume":"29","author":"Koga","year":"1999","journal-title":"Hepatology"},{"key":"R10-2-20210129","first-page":"4997","article-title":"Expression of cyclooxygenase-2 in human lung carcinoma.","volume":"58","author":"Wolff","year":"1998","journal-title":"Cancer Res"},{"key":"R11-2-20210129","first-page":"991","article-title":"Cyclooxygenase-2 expression is upregulated in squamous cell carcinoma of the head and neck.","volume":"59","author":"Chan","year":"1999","journal-title":"Cancer Res"},{"key":"R12-2-20210129","first-page":"303","article-title":"Expression of cyclooxygenase 2 in human malignant melanoma.","volume":"61","author":"Denkert","year":"2001","journal-title":"Cancer Res"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00008390-200112000-00005","article-title":"Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.","volume":"11","author":"Vogt","year":"2001","journal-title":"Melanoma Res"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00262-008-0631-1","article-title":"Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma.","volume":"58","author":"Johansson","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/B:BREA.0000036797.86601.cc","article-title":"Reproducible immunohistochemical criteria based on multiple raters judgments for expression of thymidine phosphorylase in breast cancer tissue.","volume":"86","author":"Tsuda","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/1097-0215(20000915)87:6<812::AID-IJC9>3.0.CO;2-A","article-title":"Germline alterations in the cyclooxygenase-2 gene are not associated with the development of extracolonic manifestations in a large Swiss familial adenomatous polyposis kindred.","volume":"87","author":"Humar","year":"2000","journal-title":"Int J Cancer"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1210\/jcem.86.5.7442","article-title":"Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrineparacrine regulation of neoplastic cell function via EP2EP4 receptors.","volume":"86","author":"Sales","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s004320100293","article-title":"Expression of angiogenic factors and tumor progression in human neuroblastoma.","volume":"127","author":"Komuro","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-60327-040-3_7","article-title":"High-throughput real-time PCR.","volume":"429","author":"Schmittgen","year":"2008","journal-title":"Methods Mol Biol"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/CAD.0b013e32816ebede","article-title":"Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells.","volume":"18","author":"Puglisi","year":"2007","journal-title":"Anticancer Drugs"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3835(02)00358-0","article-title":"Induction of thymidine phosphorylase by interferon and taxanes occurs only in human cancer cells with low thymidine phosphorylase activity.","volume":"187","author":"Fukushima","year":"2002","journal-title":"Cancer Lett"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00008390-200310000-00008","article-title":"Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.","volume":"13","author":"Giatromanolaki","year":"2003","journal-title":"Melanoma Res"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/CMR.0b013e32832e0bde","article-title":"Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies.","volume":"19","author":"Kuzbicki","year":"2009","journal-title":"Melanoma Res"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-4632.2010.04628.x","article-title":"Immunohistochemical expression of cyclooxygenage-2 in melanocytic skin lesions.","volume":"50","author":"Minami","year":"2011","journal-title":"Int J Dermatol"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/cncr.24902","article-title":"A phase 2 pilot trial of low-dose, continuous infusion, or metronomic paclitaxel and oral celecoxib in patients with metastatic melanoma.","volume":"116","author":"Bhatt","year":"2010","journal-title":"Cancer"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/cncr.20574","article-title":"Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.","volume":"101","author":"Reichle","year":"2004","journal-title":"Cancer"},{"key":"R28-2-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00280-003-0678-9","article-title":"Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot study.","volume":"52","author":"Spieth","year":"2003","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0b013e32835e7734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T15:36:18Z","timestamp":1644334578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201304000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e32835e7734","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}